Should I Sell My Company Before the AI Funding Cycle Peaks?

ASK PAGE BRIEF — Should I sell my company before the AI funding cycle peaks?

URL: /ask/should-i-sell-my-company-before-the-ai-funding-cycle-peaks Status update Sep 29: Full draft below — ready for Lovable publish (pending PKCE re-auth)

---

Page Title

Should I Sell My Company Before the AI Funding Cycle Peaks?

Meta Description (155 chars)

AI funding hit $392B in H1 2026. But that capital isn't flowing to your company. Here's how to read the exit window and act before it closes.

Answer (ExitBoard voice — Jason Kirby)

The AI funding cycle peaked at unprecedented levels in H1 2026 — $392 billion in just six months across North America, driven by mega-rounds to Anthropic, OpenAI, and a handful of frontier AI labs. If you're asking whether to sell before the cycle peaks, you're asking the right question but probably the wrong version of it.

The more useful question is: are you in the cohort the market is paying for?

Here's the honest breakdown: 88.8% of VC deal value in Q1 2026 went to AI companies. That concentration means the headline market recovery is real — and almost completely irrelevant to most founders. If you're running a non-AI SaaS company, you're not raising in the same market as OpenAI. You're raising in a market where every VC's reference point is a company growing 300% year-over-year. That reference point is working against your valuation multiple.

What the actual exit window looks like right now

The M&A market for non-AI companies is currently the most active it's been since 2021. Q1 2026 saw 620+ SaaS transactions. Eight deals above $5B closed in a 60-day window (Google/Wiz $32B, Thoma Bravo/Dayforce $12.3B, IBM/Confluent $11B, Capital One/Brex $5.15B, among others). PE dry powder is at record highs. Strategic acquirers are buying capability they'd otherwise have to build.

But the window has a duration. Based on deal flow analysis, the current M&A re-pivot window runs approximately February 2026 through August 2027 — roughly 12-18 months from the point when the IPO market effectively closed for non-AI companies. When the PE dry powder is deployed and strategic acquirers fill their tech roadmaps, the window compresses and multiples drop further.

Who should be moving now

• Companies with $3M–$30M ARR, 30%+ growth, NRR above 110%
• Companies raised at 2020-2022 valuations that haven't had a meaningful up-round since
• Founders who've been waiting for the IPO window — it's not opening for non-AI SaaS in this cycle
• Companies in verticals where PE is actively deploying (security, fintech infrastructure, healthcare tech, compliance)

Who can afford to wait

• AI-native companies with genuine product-market fit — you're in the favored cohort, the IPO window will open for you
• Companies with $50M+ ARR, profitable, growing 40%+ — you have multiple exit paths and leverage to negotiate
• Companies with genuine strategic moats that won't be commoditized in the next 18 months

The honest answer

If you're not sure whether to sell before the cycle peaks, the answer is: get your financials exit-ready and run a quiet process to understand your real market. You don't have to take a deal. But knowing what you're actually worth — versus what you hope to be worth in 2028 — is the most important data point you can have right now.

Call to Action

Get a real read on your exit options → [Book a Founder Clarity Session] (Calendly: https://calendly.com/jason-kirby-thunder/fundraising-demystified)

Internal links

• /ask/what-exit-multiple-should-i-expect-for-my-saas-company-in-2026
• /ask/should-i-take-a-down-round-in-2026
• /ask/how-long-does-it-take-to-sell-a-company

Keywords targeted

• should I sell my startup 2026
• AI funding cycle exit timing
• sell company before market peak
• SaaS exit window 2026
• when to sell a startup

--- NOTE: Lovable publish blocked pending PKCE re-auth (task 86bc2j7fy in Approval Queue). Once Jason completes re-auth, this page and 21 others in the queue can be published autonomously.